Showing results (101-110 of 256) with videos related to
Sort By:
Pageof 26
Blood|July 16, 2008
Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathwayJacopo Mariotti, Jason Foley, Kaitlyn Ryan, et al.Blood|March 9, 2007
Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine productionJames T Snyder, Jijia Shen, Hooman Azmi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Discordant functional and inflammatory parameters in multiple sclerosis patients after autologous haematopoietic stem cell transplantationKathleen M Healey, Steven Z Pavletic, Jinan Al-Omaishi, et al.Iscience|November 29, 2023
Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNAYifan Pang, Temesgen E Andargie, Moon Kyoo Jang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.Blood|February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantationDaniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2010
Microchimerism in salivary glands after blood- and marrow-derived stem cell transplantationSimon D Tran, Robert S Redman, A John Barrett, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2018
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single InstitutionRicardo Melendez-Munoz, Rachel Marchalik, Theresa Jerussi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2012
Cell fate control gene therapy based on engineered variants of human deoxycytidine kinaseAnton Neschadim, James C M Wang, Takeya Sato, et al.Proceedings of Spie--The International Society for Optical Engineering|December 26, 2025
Improving U-Net Segmentation of Cutaneous Chronic Graft-Versus-Host Disease in Clinical Photographs with Semi-Supervised TrainingAndrew J McNeil, Kelsey Parks, Michael Pogharian, et al.Pageof 26